Published in J Biomed Mater Res on July 01, 1975
The story of Bioglass. J Mater Sci Mater Med (2006) 2.53
Short term bonding behaviour of bioglass coatings on metal substrate. Arch Orthop Trauma Surg (1979) 0.81
Bioactive Glasses: Frontiers and Challenges. Front Bioeng Biotechnol (2015) 0.77
Hard tissue regeneration using bone substitutes: an update on innovations in materials. Korean J Intern Med (2015) 0.75
Glass-ceramic metal composite bone fixation: effect of surface parameters. Arch Orthop Trauma Surg (1985) 0.75
The future of bioactive ceramics. J Mater Sci Mater Med (2015) 0.75
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol (1989) 4.53
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet (1993) 3.03
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res (1982) 3.02
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet (2001) 2.44
Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun (2000) 2.28
Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res (2001) 2.24
The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J (2001) 2.21
Surface-active biomaterials. Science (1984) 2.21
Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St James Survey, Trinidad. Lancet (1982) 2.11
High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet (1986) 2.04
Antithrombin III and arterial disease. Lancet (1991) 1.98
Letter: High-density lipoprotein and atherosclerosis. Lancet (1975) 1.93
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis (2000) 1.90
Ethnic variation in forced expiratory volume and forced vital capacity of African and Indian adults in Guyana. Am Rev Respir Dis (1970) 1.87
Vigorous exercise in leisure time, coronary risk-factors, and resting electrocardiogram in middle-aged male civil servants. Br Heart J (1976) 1.69
Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering. Calcif Tissue Int (2000) 1.68
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
Surgical correction of the snapping iliopsoas tendon. Am J Sports Med (1991) 1.63
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
Spectroscopic study of human lung epithelial cells (A549) in culture: living cells versus dead cells. Biopolymers (2003) 1.61
The same normal cell protein is phosphorylated after transformation by avian sarcoma viruses with unrelated transforming genes. Mol Cell Biol (1981) 1.59
Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res (1998) 1.57
Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res (1973) 1.55
TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res (2001) 1.55
The snapping hip syndrome. Am J Sports Med (1984) 1.51
Haemostatic changes that constitute the hypercoagulable state. Lancet (1991) 1.47
Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol (1994) 1.47
Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) (1985) 1.42
Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet (1986) 1.41
An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax (1971) 1.38
Characteristics relevant to cardiovascular disease among adults of African and Indian origin in Guyana. Bull World Health Organ (1970) 1.37
Solution effects on the surface reactions of a bioactive glass. J Biomed Mater Res (1993) 1.36
The light-harvesting chlorpohyll-protein complex of photosystem II. Its location in the photosynthetic membrane. J Cell Biol (1976) 1.34
The lipoid pneumonia of blackfat tobacco smokers in Guyana. Q J Med (1971) 1.32
Toxicology and biocompatibility of bioglasses. J Biomed Mater Res (1981) 1.31
Lung function of healthy boys and girls in Jamaica in relation to ethnic composition, test exercise performance, and habitual physical activity. Thorax (1977) 1.30
High density lipoproteins and atherosclerosis. Annu Rev Med (1980) 1.30
HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol (2001) 1.29
Bioglass/high density polyethylene composite for soft tissue applications: preparation and evaluation. J Biomed Mater Res (1998) 1.29
An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater (1991) 1.29
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet (2003) 1.27
In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses. J Biomed Mater Res (2002) 1.26
High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet (1985) 1.26
Histopathology of malignant lesions of the penis. Urol Clin North Am (1992) 1.25
Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet (2001) 1.23
Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res (1996) 1.22
Physical and biological aspects of repair in dog cortical-bone transplants. J Bone Joint Surg Am (1975) 1.20
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. Am J Med (2001) 1.19
Molecular analysis of multifocal prostate cancer lesions. J Pathol (1999) 1.19
Mid-Missouri stroke survey: a preliminary report. Mo Med (1966) 1.19
Computer modeling of prostate biopsy: tumor size and location--not clinical significance--determine cancer detection. J Urol (1998) 1.18
Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues. Am J Pathol (1997) 1.18
Recognizing phosphatidylinositol 3-phosphate. Cell (2001) 1.18
Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res (1999) 1.17
Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis (1986) 1.17
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis (2005) 1.17
Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. J Biomed Mater Res (1997) 1.14
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia (2006) 1.14
Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass for tissue engineering applications. Biomaterials (2002) 1.12
In situ monitoring of cell death using Raman microspectroscopy. Biopolymers (2004) 1.12
A community survey of respiratory disease among East Indian and African adults in Guyana. Thorax (1971) 1.12
Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol (2000) 1.12
Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arterioscler Thromb Vasc Biol (1997) 1.11
Comparison of the bronchial response to running and cycling in asthma using an improved definition of the response to work. Thorax (1975) 1.10
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation (2000) 1.10
Bacteriostatic action of a novel four-component bioactive glass. J Biomed Mater Res (2000) 1.09
Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res (1997) 1.09
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol (1995) 1.09
Dose-dependent behavior of bioactive glass dissolution. J Biomed Mater Res (2001) 1.08
Calcium phosphate formation on sol-gel-derived bioactive glasses in vitro. J Biomed Mater Res (1994) 1.06
Widely used prostate carcinoma cell lines share common origins. Prostate (2001) 1.04
A comparison of T-wave inversion, S-T elevation, and RS amplitudes in precordial leads of Africans and Indians in Guyana. Am Heart J (1971) 1.04
Rapid microwave-stimulated fixation of entire prostatectomy specimens. Biomed-II MPC Study Group. J Pathol (1997) 1.04
Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost (2001) 1.03
Primary carcinoid tumor of the testicle: a case report and management schema. J Urol (1992) 1.03
Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Cell Growth Differ (1996) 1.03
Influence of Heavy Water on Growth, Morphology, and Fermentation Reactions of Eberthella typhosa. J Bacteriol (1946) 1.03
Quantitative comparison of bone growth behavior in granules of Bioglass, A-W glass-ceramic, and hydroxyapatite. J Biomed Mater Res (2000) 1.03
Diffuse pulmonary fibrosis and blackfat-tobacco smoking in Guyana. Lancet (1968) 1.02
CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. Prostate (1998) 1.02
Discrimination between ricin and sulphur mustard toxicity in vitro using Raman spectroscopy. J R Soc Interface (2004) 1.01
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology (1996) 1.01
Effect of hydroxyapatite impregnation on skeletal bonding of porous coated implants. J Biomed Mater Res (1980) 1.01
Lung function and exercise performance of healthy Caribbean men and women of African ethnic origin. Q J Exp Physiol Cogn Med Sci (1972) 1.00
Compositional dependence of the formation of calcium phosphate films on bioglass. J Biomed Mater Res (1980) 1.00
A 3-D reconstruction algorithm for interpolation and extrapolation of planar cross sectional data. IEEE Trans Med Imaging (1995) 1.00
1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res (1999) 1.00
Ferromagnetism in the Mott insulator Ba2NaOsO6. Phys Rev Lett (2007) 1.00
Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths. J Biomed Mater Res A (2004) 0.99
Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res (2001) 0.98
Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst. Proc Natl Acad Sci U S A (1979) 0.98
Primary iliopsoas bursography in the diagnosis of disorders of the hip. Clin Orthop Relat Res (1987) 0.97
Model breasts for use in teaching breast self-examination. J Bioeng (1978) 0.97